782-I Phase I dose escalation of SAR445710, a PDL1-IL15 targeted cytokine in metastatic and/or advanced solid tumors

782-I Phase I dose escalation of SAR445710, a PDL1-IL15 targeted cytokine in metastatic and/or advanced solid tumors

Bibliographic Details
Main Authors:	Jason Luke, Ahmad A Tarhini, Anthony J Olszanski, Chen Zhu, Giovanni Abbadessa, Christos Fountzilas, Lee Rosen, Adyb Baakili, Timothy Wagenaar, Helene Guillemin-Paveau, Meijing Wu, Raymond Perez
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

512 Phase I dose escalation of KD033, a PDL1-IL15 bispecific molecule, in metastatic and advanced solid tumors
by: Igor Puzanov, et al.
Published: (2021-11-01)

551 Pegasus Skin, a study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL2) with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancers
by: Paolo A Ascierto, et al.
Published: (2021-11-01)

779 A phase 1/2, open label, first-in-human, dose escalation and expansion study of SAR445877 administered as monotherapy in adults with advanced solid tumors
by: Aung Naing, et al.
Published: (2023-11-01)

782 consecutive construction work accidents: who is at risk?
by: Frank Frickmann, et al.
Published: (2012-08-01)

Anti PD-1/Anti PDL-1 Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Meta-Analysis of Phase 2/3 Randomized Controlled Trials
by: Kanak Parmar, et al.
Published: (2022-09-01)

P782: Validation of low-pass genome sequencing for prenatal diagnosis
by: Chloe Mighton, et al.
Published: (2024-01-01)

Pulau Tioman : L7S F782 (149-161) [aerial photograph]
by: Malaysia. Direktorat Pemetaan Negara
Published: (1990)

Interpreting Reo Circuits as PDL models
by: Erick Grilo, et al.
Published: (2022-01-01)

PDL1 expression on monocytes is associated with plasma cytokines in Tuberculosis and HIV.
by: Wegene Tamene, et al.
Published: (2021-01-01)

CONSTANTIN SCHIFIRNEȚ, C. Rădulescu-Motru. Viața și faptele sale. (vol. I), București, Editura Albatros, 2003, 782 p.
by: Constantin Aslam
Published: (2004-05-01)

Pulau Tioman : L8N F782 (163-171) [aerial photograph]
by: Malaysia. Direktorat Pemetaan Negara
Published: (1990)

Pulau Tioman : L6N F782 (96-114) [aerial photograph]
by: Malaysia. Direktorat Pemetaan Negara
Published: (1990)

Pulau Tioman : L4N F782 (48-69) [aerial photograph]
by: Malaysia. Direktorat Pemetaan Negara
Published: (1990)

P782: IMMUNOPHENOTYPIC AND MOLECULAR GENETIC MARKERS OF UNFAVORABLE PROGNOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
by: H. Trubkina, et al.
Published: (2022-06-01)

VISTA, PDL-L1, and <i>BRAF</i>—A Review of New and Old Markers in the Prognosis of Melanoma
by: Andreea Cătălina Tinca, et al.
Published: (2022-01-01)

Identification of candidate genes and prognostic value analysis in patients with PDL1-positive and PDL1-negative lung adenocarcinoma
by: Xiaoguang Qi, et al.
Published: (2020-06-01)

Adequacy of care management of patients with polyhandicap in the French health system: A study of 782 patients.
by: Marie-Christine Rousseau, et al.
Published: (2018-01-01)

Proving the Decidability of the PDLxPDL Product Logic
by: P. Balbiani, et al.
Published: (2009-07-01)

Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond
by: Mina Fazel, et al.
Published: (2023-03-01)

Immune-Omics Networks of <i>CD27</i>, <i>PD1</i>, and <i>PDL1</i> in Non-Small Cell Lung Cancer
by: Qing Ye, et al.
Published: (2021-08-01)

Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects
by: Tyler Curiel, et al.
Published: (2023-02-01)

Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro
by: Amy H. Lin, et al.
Published: (2017-03-01)

GDF15 Supports the Inflammatory Response of PdL Fibroblasts Stimulated by <i>P. gingivalis</i> LPS and Concurrent Compression
by: Albert Stemmler, et al.
Published: (2021-12-01)

A goal-directed decision procedure for hybrid PDL
by: Kaminski, M, et al.
Published: (2014)

PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy.
by: Anne-Marit Sponaas, et al.
Published: (2015-01-01)

782-B FID-007: nanoencapsulated paclitaxel derived from a novel nano-drug delivery platform
by: William Witham
Published: (2023-11-01)

Effect of omega(782) resonance on the response functions for d(e,e’π<sup>+</sup>)nn reaction
by: M. .. Tammam, et al.
Published: (2021-11-01)

A. I. STARCZEWSKA, Listy do Ciebie, Warszawa 1990
by: Tadeusz Olszański
Published: (1993-06-01)

Decision procedure for a combination of logics KD4 and PDL
by: Aida Pliuškevičienė
Published: (2004-12-01)

利用ZEMAX软件分析光器件中的PDL
by: 张博, et al.
Published: (2008-01-01)

A Canonical Model Construction for Iteration-Free PDL with Intersection
by: Florian Bruse, et al.
Published: (2016-09-01)

Real de-escalation or escalation in disguise?
by: Maggie Banys-Paluchowski, et al.
Published: (2023-06-01)

Association between Chronic Gingivitis and Cancer: A Retrospective Cohort Study of 19,782 Outpatients from the United Kingdom
by: Jane Beger-Luedde, et al.
Published: (2023-03-01)

782-F Pseudoprogression and subsequent shrinkage of refractory/relapsed pediatric solid tumors induced by GAIA-102: an interim report of the single-agent cohort in Phase I clinical trial
by: Tatsuro Tajiri, et al.
Published: (2023-11-01)

Engineered extracellular vesicles for concurrent Anti-PDL1 immunotherapy and chemotherapy
by: Yundi Chen, et al.
Published: (2022-03-01)

Regulation of Autophagic Signaling by Mechanical Loading and Inflammation in Human PDL Fibroblasts
by: Kim Blawat, et al.
Published: (2020-12-01)

PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma
by: Emilien Billon, et al.
Published: (2019-11-01)

P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
by: Jun-Ho Jang, et al.
Published: (2023-08-01)

782-G The correlation of tumor immune microenvironment with response to neoadjuvant chemotherapy response in undifferentiated pleiomorphic sarcomas: an analysis of the NEOSARCOMICS study
by: Jean-Michel Coindre, et al.
Published: (2023-11-01)

782 TransCon TLR7/8 agonist induces sustained local and systemic immune activation in patients with solid tumors
by: David Bajor, et al.
Published: (2023-11-01)